Agenus Inc.
Anti-LAG-3 antibodies and methods of use thereof

Last updated:

Abstract:

The instant disclosure provides antibodies that specifically bind to LAG-3 (e.g., human LAG-3) and antagonize LAG-3 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.

Status:
Grant
Type:

Utility

Filling date:

11 Oct 2017

Issue date:

24 Nov 2020